Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative) - USD ($)			1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 11, 2024	Jun. 05, 2024	May 31, 2024	Mar. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Expected Volatility					122.46%	112.28%	122.46%	112.28%
Expected Dividends					0.00%	0.00%	0.00%	0.00%
Expected Term						5 years 3 months 18 days		5 years 3 months 18 days
Risk Free Rate					4.29%	3.88%	4.29%	3.88%
Expenses for General and Administration					$ 5,977,277	$ 1,385,102	$ 6,952,851	$ 2,953,478
Expenses for Research and Developement					$ 2,252,325	$ 442,113	$ 2,565,092	$ 843,910
Common stock shares issuance							140,553
Stock options grnated						65,268		65,268
Proceed from related party							$ 790,781
Employee Stock Option Replacement Program [Member]
Expected Volatility					122.46%
Restricted stock were granted under the director equity plan					10,878		10,878
Outstanding number of option		230,064
Compensation expense					$ 227,808		$ 469,911
Common stock option shares approved		981,174
Compensation expense award grant					5,055,552
Expected Dividends					0.00%
Expected Term					10 years
Risk Free Rate					4.29%
Equity Incentive Plan the 2021 Plan [Member]
Proceed from stock issuances				$ 875,000
Incentive plan, description				the Company to such non-employee director, will not exceed $750,000 in total value or, in the event such non-employee director is first appointed or elected to the Board during such calendar year, $1,000,000 in total value
2021 Incentive Plan [Member]
Shares remain available to be issued		261,090
Stock options, issued		292,515			1,031,425		1,031,425
Incentive plan, description							the aggregate number of shares of common stock available for issuance under the 2021 Plan is initially set at 1,000,000 shares; this number is automatically increased each January 1st by an amount equal to 5% of the number of common stock shares outstanding at that date, resulting in an increase in available shares under the 2021 Plan at January 1, 2024 of 119,117. On May 31, 2024, the Company’s Board of Directors amended the 2021 Plan such that the total number of shares of common stock available for issuance under the 2021 Plan would be 1,000,000 as of that date, an additional increase of 789,324 shares
2021 [Member] \| Black Scholes Pricing Model [Member]
Average weighted remaining contructual life in years							10 years
Common Stock Options [Member] \| Equity Incentive Plan the 2021 Plan [Member]
Awarded number of restricted stock					1,031,425
Compensation expense					$ 5,394,367		$ 5,487,178
Common Stock Options [Member] \| CEO 2023 Equity Award [Member]
Expected Volatility							122.46%
Awarded number of restricted stock		50,251
Awarded number of restricted stock per share		$ 7.96
Due amount for exchange of stock option		$ 400,000
Compensation expense							$ 338,815
Expected Dividends							0.00%
Expected Term							5 years
Risk Free Rate							4.29%
Warrant [Member]
Common stock shares issuance					698
Director Equity Plan [Member]
Shares remain available to be issued					429,510		429,510
9 Private Investors [Member]
Common stock shares issuance					83,887
Proceed from related party					$ 659,999
29 Private Investors [Member]
Common stock shares issuance							491,186
Proceed from related party							$ 1,763,325
Stock Compensation Plan [Member]
Compensation expense					7,549,655	$ 227,808	7,661,759	$ 469,911
Expenses for General and Administration					5,524,075		5,601,531
Expenses for Research and Developement					2,025,580		2,060,228
Restricted Stock Awards [Member]
Awarded number of restricted stock issue values							$ 50,000
Awarded number of restricted stock			37,688				445,490
Awarded number of restricted stock per share			$ 7.96
Awarded number of restricted stock issue to non-employee directors	18,819						426,671
Restricted Stock Awards [Member] \| Director Stock Option Replacement Program [Member]
Restricted stock were granted under the director equity plan		127,364
Outstanding number of option		62,451
Recognized expense stock option replacement program					678,268
Awarded number of restricted stock issue values			$ 300,000
Compensation expense							$ 16,188
Restricted Stock Awards [Member] \| Stock Award in Lieu of Unpaid Directors Fees [Member]
Restricted stock were granted under the director equity plan			261,619
Recognized expense stock option replacement program							$ 1,160,832
Awarded number of restricted stock per share							$ 7.96
Non-employee board members fee			$ 172,670
wrote off related party accounts payable					$ 172,670		$ 172,670
Description related to unpaid director fees							unpaid amounts were grossed up for taxes at an assumed tax rate of 45% and the number of shares was determined based on the Company’s closing stock price on December 29, 2023 of $1.20 per share